The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Brought to you by Scientific Education Support

The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.

View all

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Create an account and access these new features:

Bookmark content to read later

Select your specific areas of interest

View lym content recommended for you

EBMT 2021

Our live event feature page helps you keep up to date with the latest research in lymphoma and CLL, fresh from congresses worldwide!

This year, we are proud to be an official media partner at the 47th Annual Meeting of the European Society for Blood and Marrow Transplant (EBMT), which will be taking place in a virtual format on March 14–17, 2021.

This conference will provide a great selection of symposia and educational sessions related to the current challenges of hematopoietic stem cell transplantation and cellular therapy.

Ensure that you stay up to date by following our live event coverage on Twitter @lymphomahub and join the discussion using #EBMT21. Following the meeting, the Lymphoma Hub will be providing articles on key sessions, as well as interviews with leaders in the field of lymphoma and CLL — be sure to check our website often for new EBMT content!

Filter by content: